1. Home
  2. SNY
  3. SNY News

Latest Sanofi ADS (SNY) News on October 28, 2025

SNY

GlobeNewswire

24 minutes ago

Press release: Sanofi successfully prices USD 3 billion of bond issue

UPDATE - Medidata Extends Collaboration with Sanofi for the Development of New Therapies with an Improved Patient Journey
SNY

GlobeNewswire

6 hours ago

UPDATE - Medidata Extends Collaboration with Sanofi for the Development of New Therapies with an Improved Patient Journey

BioMarin Reports Third Quarter 2025 Results and Provides Corporate Update
SNY

PR Newswire

10 hours ago

BioMarin Reports Third Quarter 2025 Results and Provides Corporate Update

SNY

Morningstar Research

3 days ago

Analyst Report: Sanofi

Sanofi Jumps As Dupixent Nears $5 Billion In Sales; Trump Drug Talks Continue
SNY

Investor's Business Daily

3 days ago

Sanofi Jumps As Dupixent Nears $5 Billion In Sales; Trump Drug Talks Continue

SNY

MT Newswires

3 days ago

Sector Update: Health Care Stocks Edge Higher Late Afternoon

Sanofi SA (SNY) Q3 2025 Earnings Call Highlights: Strong Growth Driven by DUPIXENT and New Launches
SNY

GuruFocus.com

3 days ago

Sanofi SA (SNY) Q3 2025 Earnings Call Highlights: Strong Growth Driven by DUPIXENT and New Launches

SNY

MT Newswires

4 days ago

Sector Update: Health Care Stocks Advance Friday Afternoon

Sanofi (ENXTPA:SAN): Exploring Valuation Following Recent Share Price Momentum
SNY

Simply Wall St.

4 days ago

Sanofi (ENXTPA:SAN): Exploring Valuation Following Recent Share Price Momentum

Dupixent stirs Sanofi’s growth as vaccine sales cool
SNY

Pharmaceutical Technology

4 days ago

Dupixent stirs Sanofi’s growth as vaccine sales cool

SNY

MT Newswires

4 days ago

European Equities Traded in the US as American Depositary Receipts Flat in Friday Trading

SNY

MT Newswires

4 days ago

Sector Update: Health Care Stocks Edge Higher Premarket Friday

SNY

MT Newswires

4 days ago

Sector Update: Health Care

Sanofi Jumps As Third-Quarter Dupixent Sales Near $5 Billion
SNY

Investor's Business Daily

4 days ago

Sanofi Jumps As Third-Quarter Dupixent Sales Near $5 Billion

SNY

MT Newswires

4 days ago

Earnings, Central Bank Outlook Damp European Bourses Midday

Health Care Roundup: Market Talk
SNY

The Wall Street Journal

4 days ago

Health Care Roundup: Market Talk

SNY

MT Newswires

4 days ago

Sanofi Q3 Earnings, Sales Increase

Sanofi Earnings Get Boost From Dupixent, New Drugs as U.S. Talks Continue
SNY

The Wall Street Journal

4 days ago

Sanofi Earnings Get Boost From Dupixent, New Drugs as U.S. Talks Continue

SNY

Investing.com

4 days ago

Sanofi beats estimates on strong Dupixent sales, new drug launches; stock up

Earnings live: Tesla stock falls after earnings miss, American Airlines climbs, IBM and Hasbro sink
SNY

Yahoo Finance

5 days ago

Earnings live: Tesla stock falls after earnings miss, American Airlines climbs, IBM and Hasbro sink

Electra Therapeutics secures $183m to fund Phase II/III trial of ELA026
SNY

Clinical Trials Arena

5 days ago

Electra Therapeutics secures $183m to fund Phase II/III trial of ELA026

SNY

MT Newswires

5 days ago

Sanofi Expands Partnership With Medidata to Deploy Artificial Intelligence in Life Sciences Research

RECORDATI APPOINTS MIKE MCCLELLAN AS NEW CHIEF FINANCIAL OFFICER
SNY

GlobeNewswire

5 days ago

RECORDATI APPOINTS MIKE MCCLELLAN AS NEW CHIEF FINANCIAL OFFICER

Sanofi Deepens Partnership with Medidata to Expedite the Development of New Therapies with an Improved Patient Journey
SNY

GlobeNewswire

5 days ago

Sanofi Deepens Partnership with Medidata to Expedite the Development of New Therapies with an Improved Patient Journey

SNY

GlobeNewswire

5 days ago

Dassault Systèmes: Sanofi Deepens Partnership with Medidata to Expedite the Development of New Therapies with an Improved Patient Journey

SNY

Argus Research

6 days ago

Market Update: TFC, DHR, KO, TXN, CLF

Hemophilia Specialists Raise the Bar: Quality of Life and Innovation Drive Market Reordering
SNY

GlobeNewswire

6 days ago

Hemophilia Specialists Raise the Bar: Quality of Life and Innovation Drive Market Reordering

Earnings live: Netflix stock dives, AT&T, GE Vernova, and Hilton rise as Tesla earnings loom
SNY

Yahoo Finance

6 days ago

Earnings live: Netflix stock dives, AT&T, GE Vernova, and Hilton rise as Tesla earnings loom

EQT Life Sciences Co-Leads USD 183 Million Series C Financing in Electra Therapeutics
SNY

PR Newswire

6 days ago

EQT Life Sciences Co-Leads USD 183 Million Series C Financing in Electra Therapeutics

Electra Therapeutics Announces $183 Million Series C Financing to Advance First-in-Class SIRP-Targeted Therapies for Immune Disorders and Cancer
SNY

GlobeNewswire

6 days ago

Electra Therapeutics Announces $183 Million Series C Financing to Advance First-in-Class SIRP-Targeted Therapies for Immune Disorders and Cancer

Press Release: Sanofi’s efdoralprin alfa met all primary and key secondary endpoints in alpha-1 antitrypsin deficiency emphysema phase 2 study
SNY

GlobeNewswire

6 days ago

Press Release: Sanofi’s efdoralprin alfa met all primary and key secondary endpoints in alpha-1 antitrypsin deficiency emphysema phase 2 study

Emphysema Market Analysis Reveals Promising Growth Opportunities and Trends During the Forecast Period (2025-2034) | DelveInsight
SNY

PR Newswire

6 days ago

Emphysema Market Analysis Reveals Promising Growth Opportunities and Trends During the Forecast Period (2025-2034) | DelveInsight

/C O R R E C T I O N -- Sanofi-Aventis Canada Inc./
SNY

CNW Group

6 days ago

/C O R R E C T I O N -- Sanofi-Aventis Canada Inc./

Collaboration between operations and supply vital amid global shifts
SNY

Clinical Trials Arena

7 days ago

Collaboration between operations and supply vital amid global shifts

SNY

MT Newswires

7 days ago

European Equities Traded in the US as American Depositary Receipts Decline in Tuesday Trading

Earnings live: Tesla, Netflix, General Motors, Ford, and P&G to headline third quarter earnings calendar this week
SNY

Yahoo Finance

8 days ago

Earnings live: Tesla, Netflix, General Motors, Ford, and P&G to headline third quarter earnings calendar this week

Press Release: ESMO: AlphaMedixTM phase 2 data support first-in-class potential of new targeted alpha therapy in gastroenteropancreatic neuroendocrine tumors
SNY

GlobeNewswire

8 days ago

Press Release: ESMO: AlphaMedixTM phase 2 data support first-in-class potential of new targeted alpha therapy in gastroenteropancreatic neuroendocrine tumors

Press Release: Sanofi’s high-dose influenza vaccine demonstrates superior protection for older adults against hospitalization vs standard-dose
SNY

GlobeNewswire

8 days ago

Press Release: Sanofi’s high-dose influenza vaccine demonstrates superior protection for older adults against hospitalization vs standard-dose

Tesla, Netflix set to report earnings as US-China trade fight turns 'unsustainable': What to watch this week
SNY

Yahoo Finance

9 days ago

Tesla, Netflix set to report earnings as US-China trade fight turns 'unsustainable': What to watch this week

SNY

MT Newswires

11 days ago

Sanofi Says Europe Regulator Issues Negative Opinion on Chronic Graft-Versus-Host Disease Drug

SNY

MT Newswires

11 days ago

Sanofi Says European Medicines Agency Recommends Wayrilz for EU Approval

Press Release: Sanofi’s Wayrilz recommended for EU approval by the CHMP to treat immune thrombocytopenia
SNY

GlobeNewswire

11 days ago

Press Release: Sanofi’s Wayrilz recommended for EU approval by the CHMP to treat immune thrombocytopenia

Press Release: Sanofi provides update on regulatory review in the EU for Rezurock to treat chronic graft-vs-host disease
SNY

GlobeNewswire

11 days ago

Press Release: Sanofi provides update on regulatory review in the EU for Rezurock to treat chronic graft-vs-host disease

I-Mab morphs into ‘hub-and-spoke’ biotech; Astellas passes on Taysha gene therapy
SNY

BioPharma Dive

11 days ago

I-Mab morphs into ‘hub-and-spoke’ biotech; Astellas passes on Taysha gene therapy

SNY

MT Newswires

12 days ago

European Equities Traded in the US as American Depositary Receipts Rise in Thursday Trading

Does Revvity’s (RVTY) Sanofi Partnership and Expanded T1D Diagnostics Shift Its Long-Term Growth Outlook?
SNY

Simply Wall St.

12 days ago

Does Revvity’s (RVTY) Sanofi Partnership and Expanded T1D Diagnostics Shift Its Long-Term Growth Outlook?

SNY

MT Newswires

12 days ago

Exchange-Traded Funds, Equity Futures Higher Pre-Bell Thursday on AI, Bank Strength

SNY

MT Newswires

12 days ago

Sanofi, EVOQ Therapeutics Sign Collaboration, License Agreement

EVOQ Therapeutics Announces Collaboration and License Agreement with Sanofi
SNY

PR Newswire

12 days ago

EVOQ Therapeutics Announces Collaboration and License Agreement with Sanofi

Sanofi Shares Rebound 6% as Investors Weigh New Valuation Amid Pipeline Progress
SNY

Simply Wall St.

12 days ago

Sanofi Shares Rebound 6% as Investors Weigh New Valuation Amid Pipeline Progress

Top Novavax Shareholder Demands Company’s Sale
SNY

Barrons.com

14 days ago

Top Novavax Shareholder Demands Company’s Sale

Sanofi: Information concerning the total number of voting rights and shares - September 2025
SNY

GlobeNewswire

14 days ago

Sanofi: Information concerning the total number of voting rights and shares - September 2025

Nanomedicine Market Size to Reach US$ 389.52 Billion by 2033, Driven by Advancements in Targeted Therapies and Drug Delivery Innovations | According DataM Intelligence
SNY

PR Newswire

15 days ago

Nanomedicine Market Size to Reach US$ 389.52 Billion by 2033, Driven by Advancements in Targeted Therapies and Drug Delivery Innovations | According DataM Intelligence

SNY

GlobeNewswire

15 days ago

HMNC Brain Health Presents New Analysis Supporting Rationale for Combining a Genetic Patient Selection Tool with a Vasopressin V1b Receptor Antagonist in the Treatment of Depression at ISCTM Conference in Amsterdam

ITM Appoints Annette Breunig as Chief People Officer
SNY

GlobeNewswire

15 days ago

ITM Appoints Annette Breunig as Chief People Officer

Global Protein Drugs Market to Reach $655.7 Billion by 2029
SNY

GlobeNewswire

17 days ago

Global Protein Drugs Market to Reach $655.7 Billion by 2029

AstraZeneca ups investment in Virginia; Moderna vets launch VC fund
SNY

BioPharma Dive

18 days ago

AstraZeneca ups investment in Virginia; Moderna vets launch VC fund

How Positive Phase II Results for AlphaMedix at Sanofi (ENXTPA:SAN) Have Changed Its Investment Story
SNY

Simply Wall St.

18 days ago

How Positive Phase II Results for AlphaMedix at Sanofi (ENXTPA:SAN) Have Changed Its Investment Story

Why Apogee, A Rival To Regeneron And Sanofi, Rocketed 34% And Broke Out
SNY

Investor's Business Daily

18 days ago

Why Apogee, A Rival To Regeneron And Sanofi, Rocketed 34% And Broke Out

RVTY Collaborates With Sanofi for Early Detection of Type 1 Diabetes
SNY

Zacks

19 days ago

RVTY Collaborates With Sanofi for Early Detection of Type 1 Diabetes

Sanofi’s €320m bet pays off as radiopharmaceutical shows benefit in GEP-NETs
SNY

Clinical Trials Arena

19 days ago

Sanofi’s €320m bet pays off as radiopharmaceutical shows benefit in GEP-NETs

SNY

MT Newswires

20 days ago

BioVaxys Appoints James Tartaglia to Board

BenchSci Announces Three-Year License Agreement with Sanofi to Access and Use BenchSci’s ASCEND Platform
SNY

Business Wire

20 days ago

BenchSci Announces Three-Year License Agreement with Sanofi to Access and Use BenchSci’s ASCEND Platform

BIOVAXYS APPOINTS FORMER SANOFI VACCINES EXECUTIVE TO BOARD OF DIRECTORS
SNY

CNW Group

20 days ago

BIOVAXYS APPOINTS FORMER SANOFI VACCINES EXECUTIVE TO BOARD OF DIRECTORS

Cutaneous Squamous Cell Carcinoma Market Forecast Report 2025-2035, with Focus on Regeneron Pharmaceuticals, Sanofi, Merck & Co., Checkpoint Therapeutics, Incyte, and Sirnaomics
SNY

GlobeNewswire

20 days ago

Cutaneous Squamous Cell Carcinoma Market Forecast Report 2025-2035, with Focus on Regeneron Pharmaceuticals, Sanofi, Merck & Co., Checkpoint Therapeutics, Incyte, and Sirnaomics

Press Release: AlphaMedixTM (212Pb-DOTAMTATE) achieved all primary efficacy endpoints in phase 2 study, demonstrating clinically meaningful benefits in patients with gastroenteropancreatic neuroendocrine tumors
SNY

GlobeNewswire

20 days ago

Press Release: AlphaMedixTM (212Pb-DOTAMTATE) achieved all primary efficacy endpoints in phase 2 study, demonstrating clinically meaningful benefits in patients with gastroenteropancreatic neuroendocrine tumors

National Advertising Division Finds Certain Nemluvio Claims Supported; Recommends Galderma Modify or Discontinue "As Soon as 48 Hours" Claims
SNY

GlobeNewswire

21 days ago

National Advertising Division Finds Certain Nemluvio Claims Supported; Recommends Galderma Modify or Discontinue "As Soon as 48 Hours" Claims

Rare Disease Therapeutics Market to Surpass US$ 495.27 Billion by 2033 as Gene Therapy, RNA-based Drugs, and Biologics Transform Patient Care
SNY

PR Newswire

21 days ago

Rare Disease Therapeutics Market to Surpass US$ 495.27 Billion by 2033 as Gene Therapy, RNA-based Drugs, and Biologics Transform Patient Care

Sanofi (ENXTPA:SAN): Assessing Valuation After a 10% Weekly Share Price Recovery
SNY

Simply Wall St.

21 days ago

Sanofi (ENXTPA:SAN): Assessing Valuation After a 10% Weekly Share Price Recovery

SNY

MT Newswires

21 days ago

Novavax Completes Transfer of Marketing Authorization for COVID-19 Vaccine in EU to Sanofi

Novavax Continues to Deliver on Sanofi Partnership, Completing Nuvaxovid® EU Marketing Authorization Transfer and Triggering $25 Million Milestone Payment
SNY

PR Newswire

21 days ago

Novavax Continues to Deliver on Sanofi Partnership, Completing Nuvaxovid® EU Marketing Authorization Transfer and Triggering $25 Million Milestone Payment

Health Care Roundup: Market Talk
SNY

The Wall Street Journal

21 days ago

Health Care Roundup: Market Talk

Neurocrine Biosciences Appoints Mike Sibley as Senior Vice President, General Manager of Neuropsychiatry Franchise
SNY

PR Newswire

21 days ago

Neurocrine Biosciences Appoints Mike Sibley as Senior Vice President, General Manager of Neuropsychiatry Franchise

Bullous Pemphigoid Market Analysis and Forecast Report 2025-2035
SNY

GlobeNewswire

22 days ago

Bullous Pemphigoid Market Analysis and Forecast Report 2025-2035

Aqemia to Participate in Jefferies European Disruptive Tech Conference
SNY

Business Wire

22 days ago

Aqemia to Participate in Jefferies European Disruptive Tech Conference

Sanofi (SNY) Invests $625 Million in Sanofi Ventures
SNY

Insider Monkey

23 days ago

Sanofi (SNY) Invests $625 Million in Sanofi Ventures

Novavax (NVAX) Is Up 10.6% After Sanofi Expands Matrix-M Licensing Agreement - Has the Bull Case Changed?
SNY

Simply Wall St.

24 days ago

Novavax (NVAX) Is Up 10.6% After Sanofi Expands Matrix-M Licensing Agreement - Has the Bull Case Changed?

SNY

Argus Research

a month ago

Analyst Report: Regeneron Phars, Inc

SNY

MT Newswires

a month ago

Revvity Launches Program to Expand Type 1 Diabetes Diagnosis Offering

Revvity Announces Program to Revolutionize the Early Detection of Type 1 Diabetes
SNY

Business Wire

a month ago

Revvity Announces Program to Revolutionize the Early Detection of Type 1 Diabetes

Sanofi (SNY) Caps Cost of Any Insulin Product at $35 per Month; Berenberg Reaffirms Its Buy Rating
SNY

Insider Monkey

a month ago

Sanofi (SNY) Caps Cost of Any Insulin Product at $35 per Month; Berenberg Reaffirms Its Buy Rating

Pfizer Stock, Other Drugmakers Rally Again
SNY

The Wall Street Journal

a month ago

Pfizer Stock, Other Drugmakers Rally Again

SNY

MT Newswires

a month ago

European Equities Traded in the US as American Depositary Receipts Surge in Wednesday Trading

Kymera Overcomes Sanofi Deal Update, Marches Ahead With Pipeline
SNY

Zacks

a month ago

Kymera Overcomes Sanofi Deal Update, Marches Ahead With Pipeline

2025 Dermatology Treatment and Care Market Analysis Report with Impact Analysis of US Tariffs Featuring Novartis, Pfizer, Amgen, GSK, F. Hoffmann-La Roche, J&J, AbbVie, Merck, Bayer, Sanofi
SNY

GlobeNewswire

a month ago

2025 Dermatology Treatment and Care Market Analysis Report with Impact Analysis of US Tariffs Featuring Novartis, Pfizer, Amgen, GSK, F. Hoffmann-La Roche, J&J, AbbVie, Merck, Bayer, Sanofi

QuantHealth Secures Strategic Investment from Sanofi Ventures to Accelerate AI-Driven Clinical Trials
SNY

Business Wire

a month ago

QuantHealth Secures Strategic Investment from Sanofi Ventures to Accelerate AI-Driven Clinical Trials

Health Care Roundup: Market Talk
SNY

The Wall Street Journal

a month ago

Health Care Roundup: Market Talk

SNY

MT Newswires

a month ago

Drugmaker Stocks Rise Pre-Bell as Pfizer, Trump Announce Price Cut Deal

Pharma Stocks in Europe Jump After White House Unveils Drug-Buying Site
SNY

The Wall Street Journal

a month ago

Pharma Stocks in Europe Jump After White House Unveils Drug-Buying Site

SNY

MT Newswires

a month ago

Update: Market Chatter: Sanofi Reportedly Raided by EU Antitrust Regulators

SNY

MT Newswires

a month ago

Market Chatter: Sanofi Reportedly Raided by EU Antitrust Regulators

SNY

MT Newswires

a month ago

Novavax Expands Sanofi Collaboration to Cover Matrix-M in Flu Vaccine Program

Novavax Announces Progress on Sanofi Agreement
SNY

PR Newswire

a month ago

Novavax Announces Progress on Sanofi Agreement

GSK Leaps Into Buy Zone On Surprise Departure Of CEO Emma Walmsley
SNY

Investor's Business Daily

a month ago

GSK Leaps Into Buy Zone On Surprise Departure Of CEO Emma Walmsley

Bank of America Securities Maintains Buy on Sanofi (SNY)
SNY

Insider Monkey

a month ago

Bank of America Securities Maintains Buy on Sanofi (SNY)

Assessing Sanofi’s Share Price After 7% Drop and Latest FDA Approval News
SNY

Simply Wall St.

a month ago

Assessing Sanofi’s Share Price After 7% Drop and Latest FDA Approval News

SNY

MT Newswires

a month ago

Sanofi to Offer its Insulins for $35 a Month in US Starting Jan. 1, 2026

Sanofi expands patient affordability program by offering access to all its insulins for $35 per month in the US
SNY

PR Newswire

a month ago

Sanofi expands patient affordability program by offering access to all its insulins for $35 per month in the US

Trump’s overnight demand for 100% tariffs on pharmaceuticals will be ‘a meaningful commercial hit for U.S. consumers,’ top analyst says
SNY

Fortune

a month ago

Trump’s overnight demand for 100% tariffs on pharmaceuticals will be ‘a meaningful commercial hit for U.S. consumers,’ top analyst says

Anemia Treatment Market Analysis by Disease Type, Therapy Class, Route of Administration, Countries and Competitive Landscape 2025-2033
SNY

GlobeNewswire

a month ago

Anemia Treatment Market Analysis by Disease Type, Therapy Class, Route of Administration, Countries and Competitive Landscape 2025-2033

Share on Social Networks: